Matinas Biopharma Holdings Inc. (MTNB)
NYSE · Healthcare
Matinas Biopharma Holdings Inc. Shareholder Equity 2014–2023
Matinas Biopharma Holdings Inc. annual/quarterly shareholder equity history from 2014 to 2023. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Matinas Biopharma Holdings Inc. shareholder equity for the quarter ending December 31, 2023 were 19.2M, a 47.47% decrease year-over-year.
- Matinas Biopharma Holdings Inc. shareholder equity for 2023 were 19.2M, a 47.47% decrease from 2022.
- Matinas Biopharma Holdings Inc. shareholder equity for 2022 were 36.6M, a 30.21% decrease from 2021.
- Matinas Biopharma Holdings Inc. shareholder equity for 2021 were 52.5M, a 17.63% decrease from 2020.
- Matinas Biopharma Holdings Inc. shareholder equity for 2020 were 63.7M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Matinas Biopharma Holdings Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2023 | $19 |
| 2022 | $37 |
| 2021 | $52 |
| 2020 | $64 |
| 2019 | $33 |
| 2018 | $16 |
| 2017 | $11 |
| 2016 | $7 |
| 2015 | $6 |
| 2014 | $2 |
| Matinas Biopharma Holdings Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2023-12-31 | $19 |
| 2022-12-31 | $37 |
| 2021-12-31 | $52 |
| 2020-12-31 | $64 |
| 2019-12-31 | $33 |
| 2018-12-31 | $16 |
| 2017-12-31 | $11 |
| 2016-12-31 | $7 |
| 2015-12-31 | $6 |
| 2014-12-31 | $2 |
Matinas Biopharma Holdings Inc. Shareholder Equity — FAQ
Matinas Biopharma Holdings Inc. (MTNB) shareholder equity over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see MTNB's shareholder equity history?
The chart and table above show Matinas Biopharma Holdings Inc.'s shareholder equity by year and by quarter, including the growth rate.